Sleep Number Financial Statements (SNBR)
|
|
|
|
Report date
|
|
|
25.02.2020 |
02.03.2021 |
01.03.2022 |
24.02.2023 |
23.02.2024 |
|
05.11.2024 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 698 |
1 857 |
2 185 |
2 114 |
1 887 |
|
1 670 |
|
Operating Income, bln rub |
|
|
112.1 |
184.9 |
193.5 |
67.9 |
22.9 |
|
20.3 |
|
EBITDA, bln rub |
? |
|
174.0 |
246.5 |
253.9 |
135.3 |
22.9 |
|
47.5 |
|
Net profit, bln rub |
? |
|
81.8 |
139.2 |
153.7 |
36.6 |
-15.3 |
|
-16.4 |
|
|
OCF, bln rub |
? |
|
189.2 |
279.7 |
300.0 |
36.1 |
-9.03 |
|
34.2 |
|
CAPEX, bln rub |
? |
|
59.2 |
39.1 |
66.9 |
69.5 |
57.1 |
|
15.8 |
|
FCF, bln rub |
? |
|
129.9 |
240.6 |
233.1 |
-33.3 |
-66.1 |
|
18.3 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
OPEX, bln rub |
|
|
939.8 |
971.1 |
1 125 |
1 134 |
1 050 |
|
963.1 |
|
Cost of production, bln rub |
|
|
646.4 |
700.6 |
866.1 |
912.0 |
799.0 |
|
672.6 |
|
R&D, bln rub |
|
|
35.0 |
40.9 |
58.5 |
61.5 |
55.8 |
|
44.3 |
|
Interest expenses, bln rub |
|
|
11.6 |
8.92 |
6.25 |
19.0 |
42.7 |
|
48.7 |
|
|
Assets, bln rub |
|
|
806.0 |
800.1 |
919.5 |
953.9 |
950.9 |
|
864.7 |
|
Net Assets, bln rub |
? |
|
-159.4 |
-224.0 |
-425.0 |
-438.2 |
-441.9 |
|
-448.8 |
|
Debt, bln rub |
|
|
588.7 |
589.4 |
791.1 |
896.0 |
972.7 |
|
917.7 |
|
Cash, bln rub |
|
|
1.59 |
4.24 |
2.39 |
1.79 |
2.54 |
|
1.59 |
|
Net debt, bln rub |
|
|
587.1 |
585.1 |
788.7 |
894.2 |
970.1 |
|
916.1 |
|
|
Ordinary share price, rub |
|
|
49.6 |
81.9 |
76.6 |
26.0 |
14.8 |
|
15.5 |
|
Number of ordinary shares, mln |
|
|
29.5 |
27.7 |
24.0 |
22.4 |
22.4 |
|
22.6 |
|
|
Market cap, bln rub |
|
|
1 462 |
2 265 |
1 841 |
582 |
333 |
|
350 |
|
EV, bln rub |
? |
|
2 049 |
2 850 |
2 630 |
1 476 |
1 303 |
|
1 266 |
|
Book value, bln rub |
|
|
-233 |
-297 |
-495 |
-506 |
-509 |
|
-515 |
|
|
EPS, rub |
? |
|
2.78 |
5.03 |
6.40 |
1.63 |
-0.68 |
|
-0.72 |
|
FCF/share, rub |
|
|
4.41 |
8.70 |
9.70 |
-1.49 |
-2.95 |
|
0.81 |
|
BV/share, rub |
|
|
-7.89 |
-10.7 |
-20.6 |
-22.6 |
-22.7 |
|
-22.8 |
|
|
EBITDA margin, % |
? |
|
10.2% |
13.3% |
11.6% |
6.40% |
1.22% |
|
2.84% |
|
Net margin, % |
? |
|
4.82% |
7.50% |
7.04% |
1.73% |
-0.81% |
|
-0.98% |
|
FCF yield, % |
? |
|
8.89% |
10.6% |
12.7% |
-5.73% |
-19.9% |
|
5.24% |
|
ROE, % |
? |
|
-51.3% |
-62.1% |
-36.2% |
-8.36% |
3.46% |
|
3.65% |
|
ROA, % |
? |
|
10.2% |
17.4% |
16.7% |
3.84% |
-1.61% |
|
-1.89% |
|
|
P/E |
? |
|
17.9 |
16.3 |
12.0 |
15.9 |
-21.8 |
|
-21.4 |
|
P/FCF |
|
|
11.2 |
9.41 |
7.90 |
-17.5 |
-5.03 |
|
19.1 |
|
P/S |
? |
|
0.86 |
1.22 |
0.84 |
0.28 |
0.18 |
|
0.21 |
|
P/BV |
? |
|
-6.28 |
-7.63 |
-3.72 |
-1.15 |
-0.65 |
|
-0.68 |
|
EV/EBITDA |
? |
|
11.8 |
11.6 |
10.4 |
10.9 |
56.8 |
|
26.7 |
|
Debt/EBITDA |
|
|
3.37 |
2.37 |
3.11 |
6.61 |
42.3 |
|
19.3 |
|
|
R&D/CAPEX, % |
|
|
59.0% |
104.7% |
87.5% |
88.6% |
97.8% |
|
280.2% |
|
|
CAPEX/Revenue, % |
|
|
3.49% |
2.10% |
3.06% |
3.28% |
3.02% |
|
0.95% |
|
| Sleep Number shareholders |
